In keeping with this, our experimental data indicate a pro-tumourigenic function for C1orf106 in breast cancer cell lines, suggesting an important role in the transition from premalignant (MII) to carcinoma (MIII/MIV) (Figure 3a). Here, INAVA is linked to breast carcinoma.